18: NDV-3A vaccine reduces the frequency of vaginitis in patients with recurrent vulvovaginal candidiasis

Journal article

Peer reviewed

P. Nyirjesy, J.D. Sobel, J.E. Edwards, M.W. Schwarz, C.S. Schmidt and J.P. Hennessey

American journal of obstetrics and gynecology, v 215(6), pp S822-S822

Dec 2016

Additional Links

4 Record Views

Title: 18: NDV-3A vaccine reduces the frequency of vaginitis in patients with recurrent vulvovaginal candidiasis
Creators: P. Nyirjesy - Drexel University
J.D. Sobel - Wayne State University
J.E. Edwards - The Lundquist Institute
M.W. Schwarz - NovaDigm Therapeutics (United States)
C.S. Schmidt - NovaDigm Therapeutics (United States)
J.P. Hennessey - NovaDigm Therapeutics (United States)
Publication Details: American journal of obstetrics and gynecology, v 215(6), pp S822-S822
Publisher: Elsevier
Resource Type: Journal article
Language: English
Other Identifier: 991019350597104721